Clinical Trial Update: T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating T-cell depletion and stem cell transplantation for immune deficiencies and histiocytic disorders has been terminated with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chediak-higashi Syndrome
• Griscelli Syndrome
• Hematologic Diseases
• Hemophagocytic Lymphohistiocytosis
• Immunologic Diseases
• Langerhans Cell Histiocytosis
• X-linked Lymphoproliferative Disorders

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Hemophagocytic Lymphohistiocytosis, X-Linked Lymphoproliferative Disorders | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2014-04-28